Abstract:Alveolar macrophages (AMs) play a critical role during Mycobacterium tuberculosis (Mtb) infection as the first cells in the lung to encounter bacteria. We previously showed that AMs initially respond to Mtb in vivo by mounting a cell-protective, rather than pro-inflammatory response. However, the plasticity of the initial AM response was unknown. Here, we characterize how previous exposure to Mycobacterium , either through subcutaneous vaccination with Mycobacterium bovis (scBCG) or through a contained Mtb infection (coMtb) that mimics aspects of concomitant immunity, impacts the initial response by AMs. We find that both scBCG and coMtb accelerate early innate cell activation and recruitment and generate a stronger pro-inflammatory response to Mtb in vivo by AMs. Within the lung environment, AMs from scBCG vaccinated mice mount a robust interferon-associated response, while AMs from coMtb mice produce a broader inflammatory response that is not dominated by Interferon Stimulated Genes. Using scRNAseq, we identify changes to the frequency and phenotype of airway-resident macrophages following Mycobacterium exposure, with enrichment for both interferon-associated and pro-inflammatory populations of AMs. In contrast, minimal changes were found for airway-resident T cells and dendritic cells after exposures. Ex vivo stimulation of AMs with Pam3Cys, LPS and Mtb reveal that scBCG and coMtb exposures generate stronger interferon-associated responses to LPS and Mtb that are cell-intrinsic changes. However, AM profiles that were unique to each exposure modality following Mtb infection in vivo are dependent on the lung environment and do not emerge following ex vivo stimulation. Overall, our studies reveal significant and durable remodeling of AMs following exposure to Mycobacterium , with evidence for both AM-intrinsic changes and contributions from the altered lung microenvironments. Comparisons between the scBCG and coMtb models highlight the plasticity of AMs in the airway and opportunities to target their function through vaccination or host-directed therapies. Tuberculosis, a disease caused by the bacteria Mycobacterium tuberculosis (Mtb), claims around 1.6 million lives each year, making it one of the leading causes of death worldwide by an infectious agent. Based on principles of conventional immunological memory, prior exposure to either Mtb or M . bovis BCG leads to antigen-specific long-lasting changes to the adaptive immune response that can be effective at protecting against subsequent challenge. However, how these exposures may also impact the innate immune response is less understood. Alveolar macrophages are tissue-resident myeloid cells that play an important role during Mtb infection as innate immune sentinels in the lung and the first host cells to respond to infection. Here, we examined how prior Mycobacterium exposure, either through BCG vaccination or a model of contained Mtb infection, impacts the early innate response by alveolar macrophages. We find that prior exposure remodels the alveolar macrophage response to Mtb through both cell-intrinsic changes and signals that depend on the altered lung environment. These findings suggest that the early innate immune response could be targeted through vaccination or host-directed therapy and could complement existing strategies to enhance the host response to Mtb.

Release of Superoxide and Hydrogen Peroxide from Guinea-Pig Alveolar Macrophages During Phagocytosis of Mycobacterium Bovis BCG

Hydrogen Peroxide and Superoxide Release by Alveolar Macrophages from Normal and BCG-vaccinated Guinea-Pigs after Intravenous Challenge with Mycobacterium Tuberculosis.

Guinea-pig alveolar macrophages kill Mycobacterium tuberculosis in vitro, but killing is independent of susceptibility to hydrogen peroxide or triggering of the respiratory burst

The Contribution of Hydrogen Peroxide Resistance to Virulence of Mycobacterium Tuberculosis During the First Six Days after Intravenous Infection of Normal and BCG-vaccinated Guinea-Pigs.

Killing of Mycobacterium Microti by Immunologically Activated Macrophages

Activation of macrophages for antimycobacterial activity

Virulence and Resistance to Superoxide, Low Ph and Hydrogen Peroxide among Strains of Mycobacterium Tuberculosis.

Macrophage antimycobacterial mechanisms.

Superoxide production by rabbit pulmonary alveolar macrophages

Virulence of Mycobacterium-Tuberculosis and Susceptibility to Peroxidative Killing Systems

Pharmacologic Ascorbate As a Pro-Drug for Hydrogen Peroxide Release to Kill Mycobacteria.

The Susceptibility of Strains of Mycobacterium Tuberculosis to Catalase-mediated Peroxidative Killing

Vaccination of Guinea Pigs with DNA Encoding the Mycobacterial Antigen MPB83 Influences Pulmonary Pathology but Not Hematogenous Spread Following Aerogenic Infection with Mycobacterium Bovis.

Prevention of tuberculosis in macaques after intravenous BCG immunization

Activation of Mouse Peritoneal Macrophages by Maintenance in Serum-Free Medium.

Mycobacterium Tuberculosis Lipoprotein MPT83 Induces Apoptosis of Infected Macrophages by Activating the TLR2/p38/COX-2 Signaling Pathway.

Mycobacterium Tuberculosis Rv0928 Protein Facilitates Macrophage Control of Mycobacterium Infection by Promoting Mitochondrial Intrinsic Apoptosis and ROS-mediated Inflammation

Antimycobacterial Effect of Lysates Prepared from Immunologically Activated Macrophages

Phagosome-Lysosome Fusion and Cyclic Adenosine 3'-5'-monophosphate in Macrophages Infected with Mycobacterium-Microti, Mycobacterium-Bovis Bcg or Mycobacterium-Lepraemurium

Mycobacterium-Microti May Protect Itself From Intracellular Destruction By Releasing Cyclic-Amp Into Phagosomes

Exposure to Mycobacterium remodels alveolar macrophages and the early innate response to Mycobacterium tuberculosis infection